Research and Development

The Research and Development team at 858 Therapeutics focuses on discovering and optimizing small molecule drugs aimed at innovative therapeutic targets in oncology. This multidisciplinary group, comprising senior scientists and research associates, engages in cutting-edge research to uncover new insights into protein functions that regulate RNA and the innate immune response, ultimately driving the discovery of effective treatments for cancer.